Healthcare -
Biotechnology - NASDAQ - GB
$ 0.53
-1.85 %
$ 22.6 M
Market Cap
-3.12
P/E
ADAP - RESEARCH & DEVELOPMENT
Research & Development ADAP - Adaptimmune Therapeutics plc
127 M
LAST VALUE
6.71%
2 YEAR CAGR
5.18%
5 YEAR CAGR
31.55%
10 YEAR CAGR